Loading clinical trials...
Loading clinical trials...
Efficacy and Safety of a Tablet Containing Palmitoyethanolamide, Alpha Lipoic Acid, Vitamin B12, Vitamin B6 , Vitamin B1, Nicotinamide, Magnesium, Zinc, Vitamin E, and Superoxide of Dismutase in Individuals Receiving Chemotherapy
Conditions
Interventions
Epineuron
Placebo Tablets
Locations
1
Greece
University General Hospital of Thessaloniki AHEPA
Thessaloniki, Greece
Start Date
November 1, 2021
Primary Completion Date
January 31, 2025
Completion Date
December 15, 2025
Last Updated
December 26, 2025
NCT05468034
NCT04541381
NCT06340568
NCT05671510
NCT01109420
NCT06713993
Lead Sponsor
Aristotle University Of Thessaloniki
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions